10 Political Leaders Who Use Brain Enhancers

Political leaders operate under enormous pressure, with demanding schedules, international negotiations, public appearances and decisions that can have far-reaching consequences.

Do Political Leaders Use Brain Enhancers?

Political leadership is a profession in which sleep deprivation, long working hours, public scrutiny and high-pressure decisions can become routine. Presidents and prime ministers may be expected to negotiate international agreements, respond to military crises, deliver speeches and make consequential decisions after hours of meetings and limited rest. This has led to a long-standing question: have political leaders used drugs to stay alert, maintain energy or improve their mental performance?

The subject is often discussed under the umbrella of brain enhancers, cognitive enhancers, smart drugs and nootropics. These terms, however, do not all mean the same thing. Some refer to prescription medicines used to treat medical conditions, while others describe substances marketed for concentration, memory or productivity. A drug that helps someone remain awake is not necessarily a drug that improves their judgment, reasoning or decision-making.

Historical evidence reveals that some prominent leaders received amphetamine-containing medicines or other drugs that could affect alertness and mood. The reasons varied. A medication might have been prescribed after an illness, used to manage pain, or taken in an attempt to feel more energetic before an important public appearance. These circumstances should not automatically be interpreted as evidence of deliberate cognitive enhancement.

Research also complicates the popular idea that a pill can reliably make a healthy person smarter. Reviews of modafinil and methylphenidate have found that their effects on cognitive performance are limited and vary according to the task and circumstances. Modafinil may be more useful for maintaining performance during sleep deprivation than for producing a dramatic improvement in an already well-rested person.

So, which political leaders have credible histories involving these substances? The following ten profiles examine documented medication use, historical accounts and modern claims, while clearly identifying where the evidence stops.

Winston Churchill: Amphetamine Before a Major Speech

Evidence status: Historical medical research documents the prescription of an amphetamine-containing medicine.

Winston Churchill, Britain’s prime minister during much of the Second World War, is one of the clearest historical examples of a political leader receiving a stimulant shortly before a major public appearance. The episode occurred in 1953, after Churchill had suffered a stroke and was experiencing what he described as a “muzzy” feeling in his head.

A medical-history paper published in the Journal of the Royal Society of Medicine examined Churchill’s recovery and his preparations for the Conservative Party conference that October. According to the historical records discussed by the authors, Churchill asked his physician, Lord Moran, for something that would help him deliver a successful speech. Moran prescribed an amphetamine-containing preparation, probably a low-dose formulation known as Edrisal. Churchill reportedly said the medicine cleared his head and gave him confidence.

This account is relevant to the modern discussion of cognitive enhancement because amphetamines can affect alertness and arousal. However, Churchill’s experience should not be treated as proof that stimulants made him a better political leader.

The medical-history analysis cautions against attributing his celebrated speech performance to the drug. Churchill was already an experienced orator, and the available evidence cannot establish that the medicine caused his success. The prescription was also made in the context of his post-stroke symptoms, rather than as part of a modern wellness routine.

What this case tells us: A documented stimulant prescription can help historians understand how a leader managed the demands of public office. It cannot, by itself, establish that the drug improved intelligence, strategic judgment or leadership ability.

John F. Kennedy: Stimulants Amid a Complex Medical History

Evidence status: Historical medical records and biographical research document stimulant exposure.

John F. Kennedy projected the image of a youthful, energetic American president, but medical records examined after his death revealed a much more complicated picture. Kennedy experienced chronic back pain, gastrointestinal problems and Addison’s disease, among other health concerns. His treatment included several categories of medication.

Reporting by The Washington Post in 2002, drawing on newly examined medical records and historical research, described Kennedy’s use of painkillers, anti-anxiety medicines, sleeping pills, hormones and stimulants. The records included methylphenidate, commonly known by the brand name Ritalin.

Kennedy’s relationship with physician Max Jacobson, nicknamed “Dr. Feelgood,” attracted particular attention. Jacobson administered injections that reportedly included amphetamines and other substances. Historical accounts describe these injections as an attempt to relieve pain and improve how Kennedy felt, although the exact contents and effects of individual treatments are not always straightforward to reconstruct.

The distinction matters. Kennedy’s medication history was not simply a story of a healthy politician taking a smart drug to become more productive. Much of his treatment related to substantial medical problems, and his regimen involved substances with different purposes and risks.

It would also be misleading to claim that stimulants explain Kennedy’s performance during the Cuban Missile Crisis or any other major event. Historical records can document medication exposure, but they cannot reliably isolate the effects of one drug on complex decisions made amid diplomatic, military and political pressures.

What this case tells us: Kennedy’s history demonstrates why a leader’s medical records should be interpreted in context. Medication use is not proof of cognitive superiority, dependence or impaired leadership.

Anthony Eden: Medication During the Suez Crisis

Evidence status: Medical-history research documents serious illness and use of an amphetamine–barbiturate combination.

Anthony Eden became British prime minister in 1955. His premiership was overshadowed by the Suez Crisis of 1956, when Britain, France and Israel intervened militarily in Egypt following Egyptian president Gamal Abdel Nasser’s nationalisation of the Suez Canal.

Eden was also seriously unwell. A surgical injury involving his bile duct had led to recurrent complications, including episodes of cholangitis, pain and fever. Medical historians have examined whether his illness and the medicines used to manage it affected his condition during the crisis.

Research published in medical-history literature discusses Eden’s treatment and the controversy surrounding his medication. One concern was his use of Drinamyl, a preparation combining amphetamine with a barbiturate. The medicine could have stimulating effects, but its combination of ingredients also complicates any simple claim that it was a cognitive enhancer.

Eden’s case is especially significant because the political consequences of the Suez Crisis were substantial. Yet it would be an oversimplification to argue that a drug caused his decisions or Britain’s eventual retreat. The crisis involved military planning, international law, economic pressure, parliamentary politics and the opposition of the United States. Eden’s medical condition was one part of a much larger historical picture.

The broader lesson is that drugs affecting alertness or mood can become relevant to political history when leaders are ill and under extreme pressure. But a retrospective assessment must distinguish medical evidence from speculation about motives or competence.

What this case tells us: Eden’s experience is a documented example of stimulant-containing medication intersecting with political leadership, but it does not establish a direct causal link between medication and the outcome of the Suez Crisis.

Adolf Hitler: Injections, Stimulants and an Unusual Treatment Regimen

Evidence status: Historical medical records and physician accounts document extensive medication use.

Adolf Hitler’s medical treatment is one of the most extensively debated drug histories involving a twentieth-century political leader. His personal physician, Theodor Morell, treated him for years and maintained records that have been studied by historians and medical researchers.

A medical-history review describes a wide-ranging treatment regimen that included injected amphetamines, hormones, corticosteroids, topical cocaine and numerous other preparations. Some treatments were unusual, and the reasons for prescribing certain substances were not always clear.

These records are relevant to the history of stimulants, but the popular claim that Hitler simply took “brain enhancers” to run Nazi Germany leaves out essential context. Morell’s treatments were connected to reported physical symptoms and illnesses, and the precise effects of individual drugs cannot always be established from surviving records.

Historians have also debated the role of other drugs in Hitler’s later years, including Eukodal, an opioid medication. Accounts differ in their interpretation of the frequency of particular treatments and how they may have influenced his condition. Such disagreements are reasons to be cautious, not invitations to make definitive medical diagnoses from a distance.

It is particularly important not to use Hitler’s medication history as a convenient explanation for Nazi crimes or the regime’s political and military decisions. Historical responsibility rests with people, institutions and ideologies; drug use does not erase that responsibility.

What this case tells us: Hitler’s treatment records provide evidence of extensive medication use, including substances that can affect the nervous system. They do not establish that these drugs enhanced his intelligence or explain his political actions.

Franklin D. Roosevelt: A Leader Whose Health Was Partly Concealed

Evidence status: Significant health concerns are documented, but evidence for deliberate cognitive enhancement is insufficient.

Franklin D. Roosevelt led the United States through the Great Depression and most of the Second World War. His health was a closely guarded political matter, particularly because he had been left with severe mobility impairments after contracting polio.

Medical historians have also examined concerns about his declining health during the final years of his presidency. Research in medical-history literature describes the difficulty of assessing Roosevelt’s condition before the 1944 election, when he had lost weight and appeared increasingly tired. The research also highlights the limitations created by incomplete or missing medical records.

However, this does not provide sound evidence that Roosevelt used a cognitive enhancer to improve his mental performance. A tired appearance or serious medical condition is not evidence of stimulant use. Nor does the fact that a leader received medical treatment mean that the treatment was intended to increase productivity.

Roosevelt belongs in this discussion as an important example of how health secrecy can shape public perceptions of political leadership. When a leader’s medical information is restricted, later commentators may be tempted to fill gaps with confident claims. Responsible research must resist that temptation.

Roosevelt’s wartime decisions were made amid enormous challenges, including the Allied military campaign, relations with Joseph Stalin and Winston Churchill, and planning for the post-war international order. No credible conclusion about those decisions should be based on unsupported claims about brain-enhancing drugs.

What this case tells us: Roosevelt’s medical history illustrates the limits of incomplete records. There is not sufficient evidence here to classify him as a user of cognitive enhancers.

Donald Trump: Contemporary Drug Claims Require Verification

Evidence status: No verified evidence identified here that he uses a cognitive enhancer.

Modern political leaders face an information environment in which rumours about their health can spread quickly through social media, online commentary and video platforms. Donald Trump provides a contemporary example of why claims about a leader’s medication must be checked against reliable reporting rather than inferred from appearance, age or public speaking style.

Contemporary fact-checking has examined speculation about Trump’s possible connection to an unidentified recipient of an experimental obesity drug reportedly being supplied through a US Food and Drug Administration programme. The reporting concerned a disputed claim about a weight-loss drug, not verified evidence of cognitive enhancement.

Separate reporting about government proposals concerning testosterone treatment and military personnel has discussed claims about energy, physical performance and hormone treatment. That policy debate should not be confused with evidence that a particular political leader uses a brain-enhancing drug.

These distinctions are essential in an article about contemporary nootropics. A report about a proposed policy is not evidence of an individual’s personal medication. An anonymous patient is not automatically a named public figure. And speculation about a leader’s health should never be treated as a confirmed fact.

The sources reviewed for this article do not establish that Trump uses modafinil, methylphenidate or another drug specifically for cognitive enhancement.

What this case tells us: Modern claims about political leaders and smart drugs need the same standard of proof as historical claims. Repetition across websites does not transform a rumour into medical evidence.

Benito Mussolini: Why Hitler’s Drug History Should Not Be Transferred to His Allies

Evidence status: Insufficient evidence to classify him as a cognitive-enhancer user.

Benito Mussolini, Italy’s fascist dictator, is sometimes mentioned in discussions of wartime drugs because of his relationship with Hitler and the medical history of Nazi Germany. But the fact that Hitler received various medications does not establish that Mussolini used the same substances or used them to improve concentration.

Medical literature does examine Mussolini’s health. Historical articles have explored his medical history and the physicians who treated him. However, the existence of such research does not establish that Mussolini used amphetamines, modafinil or modern nootropics for cognitive enhancement.

This distinction is important because historical articles can become distorted as they are repeated online. A source may document a medical consultation, another may describe a drug used in the same period, and a later writer may combine the two into a claim that the original evidence never supported.

There is no sound basis in the sources reviewed for presenting Mussolini as a confirmed brain-enhancer user. His inclusion here is therefore a reminder to distinguish an interesting historical association from proof of personal drug use.

What this case tells us: Political alliances and shared historical circumstances do not prove that leaders used the same drugs.

Joseph Stalin: A Gap in the Evidence Is Not Proof of Use

Evidence status: Not established by the sources reviewed.

Joseph Stalin ruled the Soviet Union through a period marked by forced collectivisation, political purges, the Second World War and the consolidation of a highly centralised state. His leadership has been examined extensively by historians, including through archives that became available after the Soviet period.

However, a discussion of Stalin’s political power is not the same as a documented history of cognitive-enhancing medication. To classify a leader as a user of stimulants or nootropics, a responsible article would need credible evidence such as medical records, a reliable contemporary account, or carefully sourced historical scholarship that identifies the substance and the circumstances of its use.

The evidence reviewed for this article does not establish that Stalin used a brain enhancer for concentration, wakefulness or decision-making. It would be misleading to turn the absence of evidence into a positive claim about his drug use.

Stalin is relevant to the broader topic because discussions of political power often encourage readers to search for hidden explanations for a leader’s stamina or behaviour. Yet the size of a political figure’s responsibilities, the intensity of their working schedule or the harshness of their rule cannot establish what medicines they took.

What this case tells us: A leader’s historical importance is not evidence of cognitive-enhancer use. Claims require documentation, not inference.

Mao Zedong: Separating Medical History From Smart-Drug Claims

Evidence status: Not established by the sources reviewed.

Mao Zedong led the Chinese Communist Party and the People’s Republic of China through major political and social transformations. His leadership is the subject of extensive historical scholarship, but it is important not to confuse a leader’s medical history with evidence of cognitive enhancement.

The modern term nootropic generally refers to a substance claimed to improve cognition, such as memory, attention or executive function. The term is often applied loosely in online content, sometimes to medicines developed for entirely different purposes. Applying it retrospectively to a historical figure requires particular care.

The sources reviewed for this article do not provide sufficient evidence to state that Mao used a substance specifically to enhance cognition. Without a reliable account identifying a drug, its use and its purpose, such a claim should not appear as an established fact.

This is not a claim that every detail of Mao’s medical history is known. It is a narrower conclusion: the evidence reviewed does not justify including him among confirmed users of brain-enhancing drugs.

What this case tells us: Historical leaders should not be added to a list simply to reach a round number. A listicle is more credible when it acknowledges gaps than when it fills them with unsupported claims.

Vladimir Putin: Modern Claims Need More Than Online Repetition

Evidence status: Not established by the sources reviewed.

Vladimir Putin’s public appearances, long political career and role in international affairs make him a frequent subject of commentary about leadership, stamina and personal discipline. But none of these factors establishes whether he uses cognitive-enhancing drugs.

In contemporary political coverage, claims about prescription medicines can circulate through social posts, opinion videos and websites that repeat one another without producing original evidence. A video may confidently discuss a supposed drug regimen without showing a medical record, naming a reliable source or distinguishing fact from speculation.

For a claim about a public figure’s medication to be publishable as fact, the standard should be higher. Credible documentation might include an on-record statement, authenticated records released through a legitimate process, or well-sourced reporting from a reputable news organisation. Anonymous speculation about a person’s health is not an adequate substitute.

The sources reviewed for this article do not establish that Putin uses modafinil, methylphenidate or another drug for cognitive enhancement. It would therefore be inaccurate to present him as a confirmed user.

What this case tells us: Contemporary leaders are not exempt from the need for evidence. A claim does not become reliable simply because it appears in multiple online videos or search results.

What Counts as a Brain Enhancer?

The term brain enhancer can refer to very different substances, which is one reason articles on this subject can be misleading.

  • Prescription stimulants: Medicines such as methylphenidate and amphetamine-based drugs are used for specific medical indications. They can increase alertness, but they also carry risks and are not guaranteed to improve complex reasoning.
  • Wakefulness-promoting medicines: Modafinil is prescribed for certain sleep-related disorders. Research has examined its effects on attention and other cognitive tasks, particularly when sleep is restricted.
  • Medicines used for pain, anxiety or sleep: These may influence alertness, mood and performance, but their primary purpose is not necessarily cognitive enhancement.
  • Supplements marketed as nootropics: Products containing ingredients such as caffeine or other compounds are often promoted for focus and productivity. Marketing claims may exceed the strength of clinical evidence.

The important question is not simply whether a substance affects the brain. Many medicines do. The more precise questions are whether a substance reliably improves a meaningful cognitive function, for whom it works, under what conditions, and at what risk.

Reviews of modafinil and methylphenidate have found that evidence for enhancement in healthy individuals is mixed. Modafinil showed more consistent benefits in some conditions involving sleep deprivation, while its potential to enhance cognition in well-rested adults was limited. These findings do not support the idea that either medicine reliably turns a healthy person into a better strategist or leader.

Do Brain Enhancers Improve Political Decision-Making?

There is no simple scientific test that can establish whether a drug makes a president or prime minister better at governing. Political decision-making involves many interacting abilities: attention, memory, emotional regulation, risk assessment, communication, experience and the capacity to consider competing information.

A medicine might improve wakefulness without improving judgment. A person may feel more confident while their actual performance changes very little. In a high-pressure environment, increased alertness can be useful, but it does not automatically lead to better decisions.

There are also practical difficulties in studying political leaders. Researchers cannot easily run controlled trials in which leaders take a drug before a diplomatic summit and are randomly assigned to different outcomes. Historical analysis instead relies on medical records, diaries, correspondence, contemporary accounts and later scholarship. These sources can be informative, but they rarely establish a clean cause-and-effect relationship.

The Churchill case illustrates the problem. The records support the conclusion that he received an amphetamine-containing medicine before an important speech. They do not prove that the drug caused the quality of his performance. Likewise, Kennedy’s documented exposure to stimulants cannot explain his decisions without accounting for his illnesses, advisers, experience and the circumstances of each event.

The same caution applies when a leader makes a serious political error. It is not responsible to blame medication without credible evidence. Doing so can obscure the roles of policy choices, institutions, advisers and geopolitical pressures.

The Risks of Using Stimulants for Productivity

The historical cases also raise a wider question: what happens when people use medication to meet demands that their bodies cannot comfortably sustain?

Prescription stimulants can have legitimate medical uses, but they are not risk-free productivity tools. Depending on the medicine, dose and individual, possible adverse effects can include insomnia, anxiety, increased heart rate and elevated blood pressure. Some stimulant medicines also carry risks of misuse, dependence and other serious complications.

Sleep is particularly important. Remaining awake for longer does not necessarily mean maintaining the quality of one’s thinking. A person may continue working while their attention, judgment or ability to evaluate information deteriorates. Research on modafinil suggests that wakefulness and performance are related but distinct: maintaining alertness under sleep deprivation does not guarantee that cognitive decline will be prevented.

Historical leaders faced very different medical standards from those applied today. A treatment that was available or commonly prescribed decades ago may not meet current standards of evidence or safety. Churchill’s 1953 prescription, for example, occurred in a different medical context from the modern use of prescription stimulants. It should not be taken as a recommendation for people who want to improve productivity.

Anyone considering medication for concentration, fatigue or memory should speak with a qualified healthcare professional rather than copying a historical figure’s treatment. Persistent fatigue can have many causes, including inadequate sleep, stress and underlying health conditions. Identifying the cause is generally more useful than trying to suppress the symptoms.

Why the Evidence Matters More Than the Headline

The phrase “10 political leaders who use brain enhancers” is attractive as a search headline, but it implies something that the available evidence cannot fully support. Historical research provides credible accounts of stimulant-containing medicines in the lives of Churchill, Kennedy and Eden. Hitler’s medical records also document extensive use of substances affecting the nervous system, although his treatment had a different context.

For Roosevelt, the evidence discussed here concerns significant health problems and incomplete medical records rather than confirmed cognitive enhancement. For Trump, contemporary reporting illustrates how an unverified claim about a drug can be mistaken for a fact about a named individual. For Mussolini, Stalin, Mao and Putin, the sources reviewed do not establish that they used brain enhancers.

That distinction is not a weakness in the article. It is the difference between evidence-based journalism and a list built to satisfy a headline.

The term brain enhancer also risks flattening very different situations into one category. A medicine prescribed to treat an illness, a stimulant taken to remain awake and a supplement marketed to improve memory are not interchangeable. Their effects, risks and intended uses may differ substantially.

The most defensible conclusion is that some political leaders have used medicines that can affect alertness, energy or cognition. The evidence does not show that ten leaders used them specifically to improve their political performance, nor that such substances reliably produce better leadership.

Conclusion: What Political History Can—and Cannot—Tell Us

The history of drugs and political leadership is more complicated than the idea that powerful people take smart drugs to gain an advantage. Some leaders received stimulants or other medications that could affect alertness and mood. In several cases, those treatments were connected to illness, pain or the medical practices of the period.

The documented experiences of Churchill, Kennedy, Eden and Hitler are historically significant, but they do not demonstrate that cognitive enhancers create better leaders. Nor is there sufficient evidence to identify ten confirmed political leaders who used drugs specifically to improve their brains.

The more useful lesson is that leadership performance depends on far more than staying awake or feeling energetic. Sound judgment, preparation, institutional support, experience and the ability to evaluate evidence all matter. A drug’s ability to influence one aspect of alertness should never be confused with proof of superior reasoning or political decision-making.

For readers interested in the intersection of neuroscience, history and power, the evidence offers a compelling story—but the most credible version is the one that separates documented facts from rumours.

Research Sources

The article draws on medical-history research and reputable reporting rather than treating online rumours as confirmed facts. The sources below are starting points for further verification and editorial fact-checking.

  • Journal of the Royal Society of Medicine: Medical-history research on Churchill’s recovery after a stroke and his 1953 amphetamine prescription.
  • The Washington Post: Reporting on Kennedy’s medical records and medication history.
  • PBS: Historical discussion of JFK’s medical treatment and injections from Max Jacobson.
  • Annals of Surgery: Research on Anthony Eden’s medical history and the Suez Crisis.
  • Journal of the Royal College of Physicians of Edinburgh: Medical-history review of Hitler’s treatment.
  • PubMed: Biomedical literature database containing systematic reviews of modafinil, methylphenidate and cognitive enhancement.
  • FactCheck.org: Examination of a 2026 claim concerning an unidentified recipient of an experimental obesity drug.

Research limitation: This article uses publicly accessible web sources, including medical journals, historical research and established news organisations. Private Google Docs cannot be verified without access being provided, and no claim has been treated as confirmed merely because it may appear in a YouTube video. The evidence reviewed does not support presenting all ten profiles as confirmed brain-enhancer users.

Frequently Asked Questions

Which political leaders have documented histories involving stimulants?

Winston Churchill, John F. Kennedy and Anthony Eden have documented histories involving stimulant-containing medicines. Adolf Hitler’s medical records also describe amphetamine injections among a wide range of treatments. Their circumstances differed, and the records do not establish that the medicines made them better leaders.

Did Winston Churchill use amphetamines?

Medical-history research indicates that Churchill received an amphetamine-containing preparation before an important speech in October 1953, after a stroke. The researchers caution against attributing his speech performance to the medicine.

Did John F. Kennedy take brain-enhancing drugs?

Historical research based on Kennedy’s medical records documents stimulant use, including Ritalin, as well as numerous other medications. However, his treatment was connected to a complicated medical history, and it is inaccurate to reduce it to a simple brain-enhancement strategy.

Do nootropics make people smarter?

Not reliably. Some substances can affect attention or wakefulness under particular conditions, but evidence for broad cognitive enhancement in healthy, well-rested adults is limited. Effects vary by substance, individual and task.

Is modafinil a safe productivity drug?

Modafinil is a prescription medicine used for specific sleep-related disorders. It should not be treated as a general-purpose productivity supplement. Its risks and suitability depend on the individual, and a medical professional should guide its use.